Reintroduction of nitrofurantoin in the treatment of uncomplicated urinary tract infection

被引:0
作者
Mahboob, Sabiha [1 ]
Rahman, Md Sayedur [1 ]
机构
[1] Bangabandhu Sheikh Mujib Med Univ, Fac Basic Sci & Paraclin Sci, Dept Pharmacol, Dhaka, Bangladesh
关键词
ESCHERICHIA-COLI; RESISTANCE DEVELOPMENT; ANTIBIOTIC-RESISTANCE; IMPACT; PREVALENCE;
D O I
10.3329/bjp.v16i3.54481
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study was designed to reintroduce an older antimicrobial nitrofurantoin to treat uncomplicated urinary tract infection and to explore the relationship between the reintroduction and corresponding shift in sensitivity pattern of the microbes. The microbial sensitivity against ciprofloxacin before intervention was 46.6%, which significantly increased after intervention (51.8%). Treatment with nitrofurantoin resulted in a total clinical cure rate of 80.6%, of which rate of clinical cure achieved in expected time was 66.1% and delayed was 14.5%. The rate of total clinical cure with nitrofurantoin corresponded closely with the proportion of urinary isolates sensitive to nitrofurantoin. i.e., 86.3%. This preliminary study revealed that revival might be an effective strategy to increase the sensitivity and to delay the emergence of resistance.
引用
收藏
页码:87 / 90
页数:4
相关论文
共 23 条
[1]   A brief history of the antibiotic era: lessons learned and challenges for the future [J].
Aminov, Rustam I. .
FRONTIERS IN MICROBIOLOGY, 2010, 1
[2]   Antibiotic resistance and its cost: is it possible to reverse resistance? [J].
Andersson, Dan I. ;
Hughes, Diarmaid .
NATURE REVIEWS MICROBIOLOGY, 2010, 8 (04) :260-271
[3]   The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance [J].
Austin, DJ ;
Kristinsson, KG ;
Anderson, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1152-1156
[4]   The impact of antibiotic use on resistance development and persistence [J].
Barbosa, TM ;
Levy, SB .
DRUG RESISTANCE UPDATES, 2000, 3 (05) :303-311
[5]   High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption [J].
Bartoloni, A ;
Bartalesi, F ;
Mantella, A ;
Dell'Amico, E ;
Roselli, M ;
Strohmeyer, M ;
Barahona, HG ;
Barrón, VP ;
Paradisi, F ;
Rossolini, GM .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (07) :1291-1294
[6]   Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man [J].
Bean, DC ;
Livermore, DM ;
Papa, I ;
Hall, LMC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (05) :962-964
[7]   Association between Antimicrobial Consumption and Resistance in Escherichia coli [J].
Bergman, Miika ;
Nyberg, Solja T. ;
Huovinen, Pentti ;
Paakkari, Pirkko ;
Hakanen, Antti J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (03) :912-917
[8]   A new strategy to fight antimicrobial resistance: the revival of old antibiotics [J].
Cassir, Nadim ;
Rolain, Jean-Marc ;
Brouqui, Philippe .
FRONTIERS IN MICROBIOLOGY, 2014, 5
[9]  
Centres for Disease Control and Prevention (CDC), 2017, EV SUPP COR EL ANT P
[10]   Prescribing vitamins at primary health care level: Exploration of facts, factors and solution [J].
Das, Adhir Kumar ;
Rahman, Md Sayedur .
BANGLADESH JOURNAL OF PHARMACOLOGY, 2010, 5 (02) :92-97